Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of NexoBrid in Subjects With Thermal Burns [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating NexoBrid for efficacy and safety in subjects with thermal burns has completed, with results posted on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thermal Burns

Drugs mentioned

• NEXOBRID (ANACAULASE-BCDB)

Snippet

Sponsor: MediWound Ltd | Conditions: Thermal Burns | Phase 3 | Status: COMPLETED | Results posted: 2023-06-27